Article Versions Notes

Feener EP, Davie RL, Murugesan N, Pethen SJ, Hampton SL, Smith MD, Audhya PK, Yea CM. Sebetralstat: A Rapidly Acting Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema. Drugs and Drug Candidates. 2024; 3(2):328-341. https://doi.org/10.3390/ddc3020019

Feener, Edward P., Rebecca L. Davie, Nivetha Murugesan, Stephen J. Pethen, Sally L. Hampton, Michael D. Smith, Paul K. Audhya, and Chris M. Yea. 2024. "Sebetralstat: A Rapidly Acting Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema" Drugs and Drug Candidates 3, no. 2: 328-341. https://doi.org/10.3390/ddc3020019

Feener, E. P., Davie, R. L., Murugesan, N., Pethen, S. J., Hampton, S. L., Smith, M. D., Audhya, P. K., & Yea, C. M. (2024). Sebetralstat: A Rapidly Acting Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema. Drugs and Drug Candidates, 3(2), 328-341. https://doi.org/10.3390/ddc3020019